Alpha 2.0
Login Register
» Journals » J Invest Dermatol

The Journal of Investigative Dermatology

The Journal of Investigative Dermatology is a renowned scientific journal that focuses on cutting-edge research in the field of dermatology. It publishes original studies, reviews, and clinical trials, covering a wide range of topics including skin biology, dermatopathology, immunology, and therapeutics. With its rigorous peer-review process, the journal serves as a valuable resource for dermatologists, researchers, and healthcare professionals seeking to advance their knowledge and understanding of skin diseases and their treatments.
Details
Abbr. J Invest Dermatol
Publisher Elsevier
Start 1938
End Continuing
Frequency Monthly, < Nov. 1975->
p-ISSN 0022-202X
e-ISSN 1523-1747
Country United States
Language English
Specialty Dermatology
Metrics
h-index / Ranks: 467 230
SJR / Ranks: 2054 1459
CiteScore / Ranks: 1834 8.90
JIF / Ranks: 979 6.5
Recent Articles
1.
Evaluating Adverse Event Reporting in Parallel Group Randomized Trials Published in Dermatology-specific Journals: A Methodological Systematic Review
Song Z, Pymento J, Bortoluzzi T, Vyas M, Uleryk E, Chan A
J Invest Dermatol . 2025 Mar; PMID: 40088967
No abstract available.
2.
The effect of IL17 antibody in psoriasis on brain structural morphology reveals significant changes in the precuneus
Mochizuki H, Brooks S, Mahmoud R, Andrade L, Teresa J, Ghiam N, et al.
J Invest Dermatol . 2025 Mar; PMID: 40088966
No abstract available.
3.
Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD
Shobnam N, Ratley G, Saksena S, Yadav M, Chaudhary P, Sun A, et al.
J Invest Dermatol . 2025 Mar; PMID: 40088241
Topical steroid withdrawal (TSW) is a controversial diagnosis advocated by patients but often confused for atopic dermatitis. We conducted a multimodal pilot study of 16 patients fitting the TSW diagnostic...
4.
Significance of Prognostic Factors Across Tumor Thicknesses in Melanoma: A National Cohort Study
Ma K, Shafique N, Tortorello G, Dheer A, Keele L, Karakousis G, et al.
J Invest Dermatol . 2025 Mar; PMID: 40086503
No abstract available.
5.
Response to Wong et al
Whiteman D, Olsen C, Pandeya N, Rosenberg P
J Invest Dermatol . 2025 Mar; PMID: 40072404
No abstract available.
6.
Comment on "Does Sex Matter? Temporal Analyses of Melanoma Trends among Men and Women Suggest Etiologic Heterogeneity."
Wong Z, Ou K, Wong Z, Faderani R, Kanapathy M, Mosahebi A
J Invest Dermatol . 2025 Mar; PMID: 40072403
No abstract available.
7.
The Changing Landscape of Photodermatology
Gao D, Lim H
J Invest Dermatol . 2025 Mar; PMID: 40072402
No abstract available.
8.
The Beauty of Fibroblasts Is Several Skin Layers Deep and Much Deeper
Scott R
J Invest Dermatol . 2025 Mar; PMID: 40072401
No abstract available.
9.
Blood transcriptome signature as indicator and predictor for efficacy of abrocitinib in treatment of atopic dermatitis
Wang Y, Yin H, Li Z, Wu H, Wang Q, Chen X, et al.
J Invest Dermatol . 2025 Mar; PMID: 40058571
Atopic dermatitis (AD) patients exhibit significant blood transcriptome alterations, reflecting systemic inflammation. The effects of abrocitinib, a Janus kinase 1 inhibitor, on the blood transcriptome of AD remain unclear. This...
10.
A Disproportionality Analysis on Benzoyl Peroxide and Its Risk of Malignancy Using the FDA Adverse Event Reporting System
Yang K, Czyz S, Zuberi R, Kreutz J, Bunick C, Jafarian F
J Invest Dermatol . 2025 Mar; PMID: 40058570
No abstract available.